Chemocentryx reported $71K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31247M 849M
AstraZeneca AZN:LN 387M 0M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Chemocentryx CCXI:US $ 0.07M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Macrogenics MGNX:US $ 0.61M 0M
Merk MRK:US $ 1788M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Novartis NOVN:VX SF 901M 0M
Omeros OMER:US $ 627K 1000
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Takeda 4502:JP Y 1676263M 0M
Teva Pharmaceutical TEVA:IT 57M 0
YTE INCY:US $ 0.22M 0M